Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improving Pancreatic Function With Elexacaftor/Tezacaftor/Ivacaftor.

Pediatric pulmonology - 1 Apr 2026

Pranske Madison, Paracha Alizay, Loncarich Carson, Hendrix-Dicken Amy D, Walter Joseph, Condren Michelle

Abstract excerpt

BACKGROUND: Due to the dysfunction and destruction of pancreatic cells in individuals with cystic fibrosis (CF), most require lifelong exogenous pancreatic enzyme supplementation. The objective of this study was to determine if elexacaftor/tezacaftor/ivacaftor (ETI) treatment improves pancreatic function in individuals with CF. METHODS: A retrospective study was conducted utilizing CF Foundation Patient Registry...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Benzodioxoles
Share to Chloride Channel Agonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exocrine Pancreatic Insufficiency

Share to Pancreatic Elastase

Share to Pyrroles

Share to Pyrrolidines

Share to Quinolines

Source

Identifiers

PMID: 41947741
DOI: 10.1002/ppul.71616

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improving Pancreatic Function With Elexacaftor/Tezacaftor/Ivacaftor.PMID 41947741Read ↗

Acute pancreatitis in pancreatic-insufficient cystic fibrosis patients treated with CFTR modulators.Semantic proximity Read ↗

Impact of elexacaftor/tezacaftor/ivacaftor on vitamin D absorption in cystic fibrosis patients.Semantic proximity Read ↗

Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI.Semantic proximity Read ↗

Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review.Semantic proximity Read ↗

Preservation of β-cell Function in Pancreatic Insufficient Cystic Fibrosis With Highly Effective CFTR Modulator Therapy.Semantic proximity Read ↗

Pancreatic complications in children with cystic fibrosis.Semantic proximity Read ↗

Elexacaftor/tezacaftor/ivacaftor can rescue pancreatic function in F508del homozygous children.Semantic proximity Read ↗

Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosis.Semantic proximity Read ↗

Energy Balance and Mechanisms of Weight Gain with Ivacaftor Treatment of Cystic Fibrosis Gating Mutations.Semantic proximity Read ↗

Persistent recovery of pancreatic function in patients with cystic fibrosis after ivacaftor.Semantic proximity Read ↗

CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis.Semantic proximity Read ↗

Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.